Literature DB >> 17461490

Hepatic venous outflow obstruction: three similar syndromes.

Ulas-Darda Bayraktar1, Soley Seren, Yusuf Bayraktar.   

Abstract

Our goal is to provide a detailed review of veno-occlusive disease (VOD), Budd-Chiari syndrome (BCS), and congestive hepatopathy (CH), all of which results in hepatic venous outflow obstruction. This is the first article in which all three syndromes have been reviewed, enabling the reader to compare the characteristics of these disorders. The histological findings in VOD, BCS, and CH are almost identical: sinusoidal congestion and cell necrosis mostly in perivenular areas of hepatic acini which eventually leads to bridging fibrosis between adjacent central veins. Tender hepatomegaly with jaundice and ascites is common to all three conditions. However, the clinical presentation depends mostly on the extent and rapidity of the outflow obstruction. Although the etiology and treatment are completely different in VOD, BCS, and CH; the similarities in clinical manifestations and liver histology may suggest a common mechanism of hepatic injury and adaptation in response to increased sinusoidal pressure.

Entities:  

Mesh:

Year:  2007        PMID: 17461490      PMCID: PMC4146966          DOI: 10.3748/wjg.v13.i13.1912

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  185 in total

1.  Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement.

Authors:  K Xu; F X He; H G Zhang; X T Zhang; M J Han; C R Wang; M Kaneko; M Takahashi; T Okawada
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

Review 2.  Thrombolysis for acute Budd-Chiari syndrome: case report and literature review.

Authors:  G S Raju; M Felver; J W Olin; S D Satti
Journal:  Am J Gastroenterol       Date:  1996-06       Impact factor: 10.864

3.  Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.

Authors:  R Or; A Nagler; O Shpilberg; S Elad; E Naparstek; J Kapelushnik; Y Cass; S Gillis; A Chetrit; S Slavin; A Eldor
Journal:  Transplantation       Date:  1996-04-15       Impact factor: 4.939

Review 4.  Budd-Chiari syndrome.

Authors:  Z G Wang; R S Jones
Journal:  Curr Probl Surg       Date:  1996-02       Impact factor: 1.909

5.  Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.

Authors:  C Rozman; E Carreras; C Qian; R P Gale; M M Bortin; P A Rowlings; R C Ash; R E Champlin; P J Henslee-Downey; R H Herzig; W Hinterberger; J P Klein; H G Prentice; J Reiffers; F E Zwaan; M M Horowitz
Journal:  Bone Marrow Transplant       Date:  1996-01       Impact factor: 5.483

6.  Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal.

Authors:  S M Shrestha; K Okuda; T Uchida; K G Maharjan; S Shrestha; B L Joshi; S Larsson; Y Vaidya
Journal:  J Gastroenterol Hepatol       Date:  1996-02       Impact factor: 4.029

7.  Epidemiological and clinical features of Budd-Chiari syndrome in Japan.

Authors:  H Okuda; H Yamagata; H Obata; H Iwata; R Sasaki; F Imai; M Okudaira; M Ohbu; K Okuda
Journal:  J Hepatol       Date:  1995-01       Impact factor: 25.083

8.  Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1.

Authors:  M Higashigawa; M Watanabe; H Nishihara; N Tabata; E Azuma; M Ido; M Ito; M Sakurai
Journal:  Leuk Res       Date:  1995-07       Impact factor: 3.156

9.  Natural history of paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; S M Lewis; M Bessler; L Luzzatto; J V Dacie
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

10.  Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease.

Authors:  L D DeLeve; X Wang; J F Kuhlenkamp; N Kaplowitz
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  31 in total

Review 1.  Paediatric liver ultrasound: a pictorial essay.

Authors:  Marco Di Serafino; Rosa Severino; Matilde Gioioso; Eugenio Rossi; Norberto Vezzali; Piernicola Pelliccia; Maria Grazia Caprio; Ciro Acampora; Raffaele Iorio; Gianfrancio Vallone
Journal:  J Ultrasound       Date:  2019-02-18

2.  Hepatic Involvement of Histiocytic Sarcoma: CT and MRI Findings.

Authors:  Takatoshi Kubo; Shigeru Kiryu; Hiroyuki Akai; Yasunori Ota; Arinobu Tojo; Hideo Yoshida; Naoya Kato; Yoshiyasu Nakano; Kuni Ohtomo
Journal:  Korean J Radiol       Date:  2016-08-23       Impact factor: 3.500

3.  Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.

Authors:  Jonathan A Yang; Tomoko S Kato; Brittney P Shulman; Hiroo Takayama; Maryjane Farr; Ulrich P Jorde; Donna M Mancini; Yoshifumi Naka; P Christian Schulze
Journal:  J Heart Lung Transplant       Date:  2012-03-28       Impact factor: 10.247

4.  Anatomical variations of hepatic veins: three-dimensional computed tomography scans of 200 subjects.

Authors:  Chi-Hua Fang; Jin-Hua You; Wan Yee Lau; Eric C H Lai; Ying-Fang Fan; Shi-Zhen Zhong; Ke-Xiao Li; Zhi-Xiang Chen; Zhong-He Su; Su-Su Bao
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 5.  Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies.

Authors:  Maria Giuseppina Cefalo; Palma Maurizi; Annalisa Arlotta; Maria Scalzone; Giorgio Attinà; Antonio Ruggiero; Riccardo Riccardi
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

6.  The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension.

Authors:  Yuksel Dogan; Aliye Soylu; Ozgur Kilickesmez; Tuna Demirtas; Kadriye Orta Kilickesmez; Sebahat Nacar Dogan; Gulay Eren; Isa Sevindir; Nurgul Yasar; Sule Poturoglu; Kenan Sonmez
Journal:  Cardiovasc Ultrasound       Date:  2010-07-21       Impact factor: 2.062

7.  Biochemical evidence of mild hepatic dysfunction identifies decompensated heart failure patients with reversible renal dysfunction.

Authors:  Meredith A Brisco; Brian D McCauley; Jennifer Chen; Chirag R Parikh; Jeffrey M Testani
Journal:  J Card Fail       Date:  2013-10-17       Impact factor: 5.712

8.  Hepatic congestion leads to fibrosis: findings in a newly developed murine model.

Authors:  Hisashi Hidaka; Yasuko Iwakiri
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

9.  Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload.

Authors:  Francesca Vinchi; Stefania Gastaldi; Lorenzo Silengo; Fiorella Altruda; Emanuela Tolosano
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

10.  Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.

Authors:  Ankur Varma; Susan C Abraham; Rohtesh S Mehta; Neeraj Y Saini; Medhavi Honhar; Munazza Rashid; Julianne Chen; Samer A Srour; Qaiser Bashir; Gabriela Rondon; Betul Oran; Chitra M Hosing; Yago Nieto; Partow Kebriaei; Amin M Alousi; Sairah Ahmed; David Marin; Issa F Khouri; Stefan O Ciurea; Muzaffar H Qazilbash; Katy Rezvani; Paolo Anderlini; Borje S Andersson; Elizabeth J Shpall; Richard E Champlin; Uday R Popat
Journal:  Blood Adv       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.